ASG
ABBV icon

Advisory Solutions Group’s AbbVie ABBV Stock Holding History

Advisory Solutions Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.74M Buy
10,491
+7,158
+215% +$1.84M 0.58% 48
2026
Q2 		$839K Buy
+3,333
New +$717K 0.28% 79

Other funds holding ABBV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Advisory Solutions Group's ABBV Position: Q3 2026 in Review

Advisory Solutions Group increased its AbbVie (ABBV) stake by 215% in Q3 2026, buying an estimated $1.84M and bringing the position to 10,491 shares worth $2.74M. The position accounts for 0.58% of the portfolio, ranked #48.

Advisory Solutions Group first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Advisory Solutions Group held 10,491 shares of AbbVie worth $2.74M as of Q3 2026.
  • Advisory Solutions Group bought 7,158 AbbVie shares in Q3 2026, an estimated $1.84M.
  • AbbVie made up 0.58% of Advisory Solutions Group's portfolio in Q3 2026, its #48 holding.
  • Advisory Solutions Group first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Advisory Solutions Group's 13F filing for Q3 2026, filed 14 Oct 2026.